TBX2 and prostate adenocarcinoma: We found that TBX2 subfamily has differential expression in Bladder Cancer (BLCA), Lung Adenocarcinoma (LUAD), Lung Squamous Cell Carcinoma (LUSC), Prostate Cancer (PRAD) and Sarcoma (SARC) compared to the matched normal tissues.